Ataraxis AI
Ataraxis AI is a clinical AI startup using digital pathology and multimodal foundation models to personalize cancer prognosis and treatment selection. Its Ataraxis Breast platform aims to help oncologists estimate recurrence risk and predict individual treatment response.
- Artificial Intelligence
- New York City, New York, United States
Company Overview
Ataraxis AI is a New York-based clinical artificial intelligence company focused on precision oncology. Founded in 2023 as a spinout from New York University, the company develops AI models that combine digital pathology images with clinical information to predict cancer outcomes and help physicians personalize treatment decisions.
Its flagship platform, Ataraxis Breast, provides AI-powered assessments of breast cancer recurrence risk and treatment response. The company also develops foundation models, including Kestrel and other specialized models, to identify clinically meaningful patterns in tumor tissue that may not be captured by conventional assessment methods alone.
QueryFeedz Insight
Ataraxis AI operates at the intersection of clinical AI, computational pathology, and precision oncology. Rather than focusing primarily on cancer detection, its technology aims to help clinicians understand how a patient's cancer may progress and which treatments may offer the greatest benefit.
Its potential competitive advantage lies in combining routine pathology images with clinical data and foundation models to generate individualized predictions without requiring additional specialized tissue preparation for its described workflows.
Funding & Investors
- Latest funding
- $20
- Latest round
- Series A
- Latest funding date
- March 2025
Investors
- AIX Ventures — Series A lead investor
- Floating Point
- Thiel Bio
- Founders Fund
- Bertelsmann Investments
- Giant Ventures
- Obvious Ventures
- Peter Thiel
- Mario Schlosser
- Ryan Fukushima
- Other angel investors, including researchers from leading AI organizations
Founders
- Jan Witowski MD, PhD — Co-Founder and Chief Executive Officer. Krzysztof Geras, PhD — Co-Founder and Chief Scientific Officer
Company Links
Prepared (Prepared911) Visit Prepared (Prepared911) website (opens in a new tab)
Artificial Intelligence
Prepared develops AI-powered software for 911 call centers, supporting real-time transcription, translation, call summarization, dispatch intelligence, and emergency-response coordination.
OpenRouter Visit OpenRouter website (opens in a new tab)
Artificial Intelligence
OpenRouter is an AI infrastructure platform providing a unified API to access, route, and optimize hundreds of AI models.
Tennr Visit Tennr website (opens in a new tab)
HealthTech
Tennr is a healthcare AI company building an agentic patient orchestration platform that automates documentation, referrals, insurance workflows, and patient communications.
EliseAI Visit EliseAI website (opens in a new tab)
HealthTech
EliseAI is an AI company founded in 2017 that builds software to automate complex operational workflows in housing…